Medclick Pharma

Entavir (Entecavir) 0.5 mg is an oral antiviral medication used primarily for the treatment of chronic Hepatitis B virus (HBV) infection. It belongs to a class of drugs called nucleoside reverse transcriptase inhibitors (NRTIs). Entecavir works by reducing the amount of HBV in the body, which helps prevent liver damage, cirrhosis, and liver cancer.

Valcivir contains Valacyclovir, an oral antiviral prodrug that is rapidly converted in the body to Acyclovir, a well-known antiviral agent. It is used to treat infections caused by the herpes viruses.

Myhep LVIR is a fixed-dose combination tablet containing Ledipasvir and Sofosbuvir, used for the treatment of chronic Hepatitis C virus (HCV) infection. It is a generic version of Harvoni® and is effective across HCV genotypes 1, 4, 5, and 6.

Ledifos is a fixed-dose combination antiviral medication used for the treatment of chronic Hepatitis C virus (HCV) infection. It contains two direct-acting antivirals (DAAs): Ledipasvir and Sofosbuvir, which work synergistically to inhibit different steps of the HCV replication cycle.

Natclovir 500 mg contains Ganciclovir, an antiviral medication used to treat and prevent cytomegalovirus (CMV) infections, especially in immunocompromised patients such as those with HIV/AIDS, organ transplant recipients, or cancer patients undergoing chemotherapy.

Hepcinat-LP is a fixed-dose combination of Ledipasvir and Sofosbuvir, used for the treatment of chronic Hepatitis C virus (HCV) infection. It is a direct-acting antiviral (DAA) therapy offering a highly effective, well-tolerated, once-daily oral regimen.

Oselvir 45 mg contains Oseltamivir, an oral antiviral medication used to treat and prevent influenza (flu types A and B). It works best when started early and is commonly prescribed during flu outbreaks, especially for high-risk individuals, such as children, the elderly, or those with weakened immune systems.

Adesera (Adefovir Dipivoxil) 10 mg is an antiviral medication used for the treatment of chronic Hepatitis B virus (HBV) infection in adults and some pediatric patients. It is a nucleotide analog reverse transcriptase inhibitor (NtRTI) that works by blocking HBV DNA polymerase, thereby preventing viral replication.

Hepcinat is a generic version of the antiviral drug Sofosbuvir, which is part of a class of medications called nucleotide analog NS5B polymerase inhibitors. It is used in combination with other antiviral agents to treat chronic Hepatitis C virus (HCV) infection.

Velpanat is a pan-genotypic, direct-acting antiviral (DAA) tablet used to treat chronic Hepatitis C virus (HCV) infection. It is the generic equivalent of Epclusa® (Sofosbuvir + Velpatasvir) and is approved for all HCV genotypes (1–6).